← All companies
AMRX annual revenue
Amneal Pharmaceuticals, Inc.
AMRX - CIK 0001723128
Market cap$4.89 B
Rank#1397
SEC filings664
Amneal Pharmaceuticals, Inc. revenue by year
Amneal Pharmaceuticals, Inc. (AMRX) reported revenue of $3.02B for fiscal year 2025, as filed in its audited annual report with the SEC.
AMRX revenue 2016-2025
| Fiscal year | Revenue | Change |
|---|---|---|
| FY 2025 | $3.02B | +8.0% |
| FY 2024 | $2.79B | +16.7% |
| FY 2023 | $2.39B | +8.2% |
| FY 2022 | $2.21B | +5.7% |
| FY 2021 | $2.09B | +5.1% |
| FY 2020 | $1.99B | +22.5% |
| FY 2019 | $1.63B | -2.2% |
| FY 2018 | $1.66B | +60.9% |
| FY 2017 |
Revenue of similar companies
Frequently asked questions
How much revenue does Amneal Pharmaceuticals, Inc. make?
Amneal Pharmaceuticals, Inc. (AMRX) reported revenue of $3.02B for fiscal year 2025, as filed in its audited annual report with the SEC.
How has Amneal Pharmaceuticals, Inc.'s revenue changed over time?
Between fiscal 2016 and fiscal 2025, Amneal Pharmaceuticals, Inc.'s revenue grew from $1.02B to $3.02B.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.